Home/Filings/4/0000899243-20-010048
4//SEC Filing

Prener Anne 4

Accession 0000899243-20-010048

CIK 0001751299other

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 8:57 AM ET

Size

5.5 KB

Accession

0000899243-20-010048

Insider Transaction Report

Form 4
Period: 2020-04-01
Prener Anne
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-04-01+30,00030,000 total
    Exercise: $5.21Exp: 2030-04-01Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]Thirty three percent of this option shall vest on April 1, 2021, with the remainder vesting in two equal annual installments thereafter, subject to Dr. Prener's continued service on the board of directors through each such date. This grant was made in accordance with the Company's Non-Employee Director Compensation Policy.

Issuer

Kaleido Biosciences, Inc.

CIK 0001751299

Entity typeother

Related Parties

1
  • filerCIK 0001797917

Filing Metadata

Form type
4
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 8:57 AM ET
Size
5.5 KB